STOCK TITAN

XpresSpa Group and United Airlines Announce the Opening of an XpresCheck™ COVID-19 Testing Facility at Houston George Bush Intercontinental Airport

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
covid-19
Rhea-AI Summary

XpresSpa Group, Inc. (Nasdaq: XSPA) recently opened its first XpresCheck testing facility in Texas at Houston George Bush Intercontinental Airport, in partnership with United Airlines. This facility aims to provide COVID-19 testing, with a capacity of over 300 tests daily, including Rapid Molecular and PCR tests. CEO Doug Satzman expressed excitement over enhancing traveler safety and convenience. The venture continues to expand the company's COVID-19 testing services, now available at nine locations across seven airports.

Positive
  • Opening of the first XpresCheck facility in Texas enhances market presence.
  • Partnership with United Airlines strengthens service offerings.
  • Facility has the capability to administer over 300 tests daily, increasing revenue potential.
Negative
  • None.

Located Post-Security, Terminal E, Operated by United Airlines

First XpresCheck in the State of Texas

NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced in collaboration with United Airlines, the opening of its XpresCheck testing facility at Houston George Bush Intercontinental Airport.

XpresCheck’s pop-up testing facility is located in United’s Terminal E post-security. It has four separate testing rooms and an anticipated capacity to administer over 300 tests per day. COVID-19 testing options include the Rapid Molecular Test and the Polymerase Chain Reaction (PCR) Test.

Doug Satzman, XpresSpa CEO, said, "We are thrilled to be opening our first XpresCheck in Texas at Houston George Bush Intercontinental Airport. This testing facility extends our partnership with United and enables us to bring convenient and reliable COVID-19 testing options to their customers and employees.”

“Offering accessible and dependable testing solutions provides peace of mind to travelers and facilitates a safer in-flight experience,” said Rodney Cox, vice president of United’s Houston hub. “This new XpresCheck location will also help ensure our customers traveling through Houston meet the entry requirements at their final destination.”

About XpresSpa Group, Inc.

XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading global health and wellness holding company. XpresSpa Group’s core asset, XpresSpa, is a leading airport retailer of spa services and related health and wellness products, with 45 locations in 23 airports globally. Through its XpresTest, Inc. subsidiary, the Company provides COVID-19 screening and testing under the XpresCheck™ brand at nine locations in seven airports: Boston Logan International Airport (2), Denver International Airport, Houston George Bush Intercontinental Airport, JFK International Airport, Newark Liberty International Airport (2), Phoenix Sky Harbor International Airport, and Salt Lake City International Airport. To learn more about XpresSpa Group, visit: www.XpresSpaGroup.com.

Twitter: @xprescheck and Instagram: @realxprescheck

About United Airlines

United's shared purpose is "Connecting People. Uniting the World." For more information, visit united.com, follow @United on Twitter and Instagram or connect on Facebook. The common stock of United's parent, United Airlines Holdings, Inc., is traded on the Nasdaq under the symbol "UAL".

Forward-Looking Statements

Forward-Looking Statements This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept, being able to expand testing to other communicable diseases as well as administer vaccinations for the seasonal flu, our positioning to be part of the national rollout of various COVID-19 vaccinations as they become available, the degree to which our public testing model assists passengers meet testing requirements in select states and countries, our ability to identify and gain access to the latest and best COVID-19 testing methodologies and equipment, and our ability further expand our initial sites and our overall ability to manage the regulatory challenges associated with this business line. Forward-looking statements relating to expectations about future results or events are based upon information available to XpresSpa Group as of today's date and are not guarantees of the future performance of the company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in XpresSpa Group’s most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q, recent Current Reports on Form 8-K and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XpresSpa Group, or other matters and attributable to XpresSpa Group or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XpresSpa Group does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

Investor Relations:
ICR
Raphael Gross
ir@xpresspagroup.com
(203) 682-8253

Media:
Julie Ferguson
Julie@jfprmedia.com
(312) 385-0098

United Airlines
David Gonzalez
david.d.gonzalez@united.com
832-671-8707


FAQ

What is the significance of XpresCheck opening at Houston George Bush Intercontinental Airport?

The opening enhances XpresSpa's market presence and provides necessary COVID-19 testing for travelers, facilitating safer journeys.

What testing options are available at the XpresCheck facility?

The facility offers Rapid Molecular and Polymerase Chain Reaction (PCR) tests for COVID-19.

How many tests can the XpresCheck facility administer daily?

The facility has a capacity to administer over 300 tests per day.

Who partnered with XpresSpa for the new testing facility?

XpresSpa partnered with United Airlines to open the XpresCheck testing facility.

Where else does XpresSpa provide COVID-19 testing?

XpresSpa operates XpresCheck testing services at nine locations across seven airports, including Boston, Denver, and JFK.

xspa

NASDAQ:XSPA

XSPA Rankings

XSPA Latest News

XSPA Stock Data

61.75M
92.82M
1.55%
18.33%
3%
Personal Services
Consumer Cyclical
Link
United States
New York